Heron Therapeutics (HRTX)
(Delayed Data from NSDQ)
$3.44 USD
-0.03 (-0.86%)
Updated May 24, 2024 03:59 PM ET
After-Market: $3.43 -0.01 (-0.29%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth B Momentum B VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 36% (90 out of 250)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.25 | 1.52 | 9.99 |
Current Quarter Estimate | -0.04 | -2.04 | 57.00 |
Year Ago Quarter Estimate | -0.35 | -0.59 | 52.54 |
Next Quarter Estimate | -0.03 | -2.00 | 61.00 |
Next Year Estimate | 0.01 | 6.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 87.50 | 13.40 | 15.67 |
Next Year | 110.00 | 14.10 | 9.31 |
Last 5 Years | NA | 6.90 | 8.10 |
Next 5 Years | NA | 23.10 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -5.88 |
Price/Book (MRQ) | NA | 1.89 |
Price/Cash Flow (MRFY) | NA | 8.49 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -61.28% | -67.62% |
Return on Equity (TTM) | NA | -59.74% |
Debt to Equity (MRQ) | -5.15 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.